DK1916995T4 - Ph-styret, pulserende indgivelsessystem, fremgangsmåder til fremstilling og anvendelse deraf - Google Patents

Ph-styret, pulserende indgivelsessystem, fremgangsmåder til fremstilling og anvendelse deraf Download PDF

Info

Publication number
DK1916995T4
DK1916995T4 DK05770631.9T DK05770631T DK1916995T4 DK 1916995 T4 DK1916995 T4 DK 1916995T4 DK 05770631 T DK05770631 T DK 05770631T DK 1916995 T4 DK1916995 T4 DK 1916995T4
Authority
DK
Denmark
Prior art keywords
pulsable
manufacture
controlled
methods
delivery system
Prior art date
Application number
DK05770631.9T
Other languages
English (en)
Other versions
DK1916995T3 (da
Inventor
Reinout Cornelus Andreas Schellekens
Henderik Willem Frijlink
Original Assignee
Stichting Groningen Centre For Drug Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35094295&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1916995(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stichting Groningen Centre For Drug Res filed Critical Stichting Groningen Centre For Drug Res
Application granted granted Critical
Publication of DK1916995T3 publication Critical patent/DK1916995T3/da
Publication of DK1916995T4 publication Critical patent/DK1916995T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK05770631.9T 2005-07-29 2005-07-29 Ph-styret, pulserende indgivelsessystem, fremgangsmåder til fremstilling og anvendelse deraf DK1916995T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2005/000559 WO2007013794A1 (en) 2005-07-29 2005-07-29 Ph-controlled pulsatile delivery system, methods for preparation and use thereof

Publications (2)

Publication Number Publication Date
DK1916995T3 DK1916995T3 (da) 2016-02-01
DK1916995T4 true DK1916995T4 (da) 2022-10-03

Family

ID=35094295

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05770631.9T DK1916995T4 (da) 2005-07-29 2005-07-29 Ph-styret, pulserende indgivelsessystem, fremgangsmåder til fremstilling og anvendelse deraf

Country Status (10)

Country Link
US (1) US11744803B2 (da)
EP (1) EP1916995B2 (da)
JP (1) JP2009502908A (da)
CN (1) CN101287443B (da)
AU (1) AU2005334837B2 (da)
CA (1) CA2617051C (da)
DK (1) DK1916995T4 (da)
ES (1) ES2560240T5 (da)
PL (1) PL1916995T5 (da)
WO (1) WO2007013794A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005334837B2 (en) 2005-07-29 2012-07-19 Stichting Groningen Centre For Drug Research PH-controlled pulsatile delivery system, methods for preparation and use thereof
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
KR101804354B1 (ko) * 2008-11-18 2017-12-04 젤레시스 엘엘씨 체중 관리 및 혈당 조절 개선을 위한 방법 및 조성물
US9675566B2 (en) 2009-07-16 2017-06-13 Pathologica Llc Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing
PL2665471T3 (pl) 2011-01-19 2018-06-29 Pathologica, Llc. Doustne farmaceutyczne postacie dawkowane o kontrolowanym uwalnianiu zawierające mgbg
EP2830599B1 (en) * 2012-03-29 2018-08-15 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
EP2943189B1 (en) 2013-01-08 2021-03-10 Pathologica LLC Mitoguazone for treatment of progressive multiple sclerosis
CN105120847B (zh) 2013-03-14 2018-12-28 塞拉拜姆有限责任公司 益生生物和/或治疗剂的靶向胃肠道递送
RU2696494C2 (ru) 2014-06-20 2019-08-02 Джелезис, Ллк Способы лечения избыточной массы тела или ожирения
WO2016020336A1 (en) * 2014-08-04 2016-02-11 Dbv Technologies Compositions of food allergens
US9901649B2 (en) 2016-05-03 2018-02-27 International Business Machines Corporation Block copolymers for therapeutic drug delivery
EP3703515A1 (en) * 2017-11-03 2020-09-09 DSM IP Assets B.V. New delivery system
BR112021021429A2 (pt) * 2019-04-30 2021-12-21 Dsm Ip Assets Bv Sistema de distribuição para vitaminas específicas solúveis em água
CN111001191A (zh) * 2019-12-23 2020-04-14 西安科技大学 一种环境友好的pH响应型油水分离材料的制备方法
JP2023552995A (ja) 2020-12-04 2023-12-20 スリーエム イノベイティブ プロパティズ カンパニー 歯科用ｐＨ感受性マイクロカプセル
EP4212149A1 (en) 2022-01-18 2023-07-19 Rijksuniversiteit Groningen Oral dosage forms of acid-labile salt and methods and uses related thereto
WO2023211276A1 (en) 2022-04-29 2023-11-02 Rijksuniversiteit Te Groningen Oral dosage system and methods for delivery of oxygen-sensitive therapeutic agent(s) to the lower gastrointestinal tract

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61100526A (ja) 1984-10-22 1986-05-19 Kyowa Hakko Kogyo Co Ltd 持続性ドパミン経黒剤
AU576907B2 (en) 1984-11-01 1988-09-08 American Home Products Corporation Oral vaccines comprising live recombinant adenoviruses
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
GB8518301D0 (en) 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
KR880701098A (ko) * 1986-04-01 1988-07-25 로버어트 에이 아미테이지 메틸프레드니솔론/소디움 카르복시메틸 전분 정제 조성물
DE3822095A1 (de) 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
ES2043270T3 (es) 1989-02-16 1993-12-16 British Tech Group Dispositivo distribuidor.
US5422121A (en) 1990-11-14 1995-06-06 Rohm Gmbh Oral dosage unit form
JP3134187B2 (ja) * 1996-03-07 2001-02-13 武田薬品工業株式会社 放出制御組成物
US6245351B1 (en) 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
JPH10130171A (ja) 1996-09-04 1998-05-19 Dot:Kk 経口投与用医薬組成物
US6650121B2 (en) 1996-09-05 2003-11-18 Robert Bosch Gmbh Sensor for the monitoring of an NOx catalyst
HRP970493A2 (en) 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
US5972319A (en) 1997-03-31 1999-10-26 The Colgate-Palmolive Company Antiperspirant stick with improved characteristics
YU49699A (sh) 1997-04-02 2002-12-10 Purdue Research Foundation Farmaceutska kompozicija i postupak njenog dobijanja
DE19732903A1 (de) * 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
AR016827A1 (es) * 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
WO1999018938A1 (en) 1997-10-09 1999-04-22 Perio Products Ltd. Delayed total release gastrointestinal drug delivery system
UA69413C2 (uk) 1998-05-22 2004-09-15 Брістол-Майерс Сквібб Компані Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
UA73092C2 (uk) 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
US6632451B2 (en) * 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
IT1318376B1 (it) 2000-03-07 2003-08-25 Pharmatec Internat S R L Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo.
JP2004507487A (ja) 2000-08-29 2004-03-11 メファ・アクチェンゲゼルシャフト 腸疾患治療薬
GB2367002A (en) 2000-09-25 2002-03-27 British Sugar Plc Coating composition
US6663888B2 (en) * 2001-12-14 2003-12-16 Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form
ES2645930T3 (es) 2003-01-03 2017-12-11 Supernus Pharmaceuticals, Inc. Utilización de una mezcla de dos o más materiales entéricos para regular la liberación de fármacos a través de una membrana o matriz para terapias sistémicas
US20050147663A1 (en) * 2003-07-17 2005-07-07 Mohan Mailatur S. Method of treatment for improved bioavailability
US20050075432A1 (en) * 2003-10-07 2005-04-07 Verrall Andrew P. Acidulent film and method of making same
AU2005334837B2 (en) 2005-07-29 2012-07-19 Stichting Groningen Centre For Drug Research PH-controlled pulsatile delivery system, methods for preparation and use thereof
US8911766B2 (en) 2009-06-26 2014-12-16 Abbott Cardiovascular Systems Inc. Drug delivery compositions including nanoshells for triggered drug release
US20150246001A1 (en) 2012-10-23 2015-09-03 Dsm Ip Assets B.V. Process for the manufacturing of a multilayer drug delivery construct

Also Published As

Publication number Publication date
ES2560240T5 (es) 2022-11-08
PL1916995T3 (pl) 2016-05-31
EP1916995B1 (en) 2015-10-28
DK1916995T3 (da) 2016-02-01
EP1916995A1 (en) 2008-05-07
ES2560240T3 (es) 2016-02-18
CA2617051C (en) 2013-12-17
PL1916995T5 (pl) 2022-10-31
AU2005334837A1 (en) 2007-02-01
EP1916995B2 (en) 2022-06-29
WO2007013794A1 (en) 2007-02-01
US20090181089A1 (en) 2009-07-16
AU2005334837B2 (en) 2012-07-19
US11744803B2 (en) 2023-09-05
JP2009502908A (ja) 2009-01-29
CN101287443B (zh) 2013-05-29
CN101287443A (zh) 2008-10-15
CA2617051A1 (en) 2007-02-01

Similar Documents

Publication Publication Date Title
DK1916995T4 (da) Ph-styret, pulserende indgivelsessystem, fremgangsmåder til fremstilling og anvendelse deraf
FI20050357A0 (fi) Matkapäätelaitteen tarkan sijainnin määrittäminen, menetelmä ja laite
DK2209375T3 (da) Parp-inhibitorforbindelser, præparater og fremgangsmåder til anvendelse deraf
NO20055686L (no) Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
DK1968429T3 (da) Fremgangsmåde og system til stabilisering af sensorer
SE0501871L (sv) Autenticeringssystem och -förfarande
SE0702458L (sv) Styrsystem och -metod
FI20050867A0 (fi) Menetelmä ja kutsujärjestelmä
DK1744590T3 (da) Høreapparat og tilsvarende fremgangsmåde til indstilling heraf
DE102005020647A8 (de) Verbinder, Verbindersystem und Verwendung
DE602006017285D1 (de) Kryptographisches Kommunikationssystem und -methode
DK1965763T3 (da) Stabile enzympræparater og fremgangsmåder til anvendelse heraf
DK1934964T3 (da) Transaktionsanordninger, systemer og fremgangsmåder
DK2902053T3 (da) Anordninger, systemer og fremgangsmåder til væskefremføring
DK1759318T3 (da) Fremgangsmåder og systemer til at administrere data
DE602006017919D1 (de) Kommunikationsspielsystem, Spielvorrichtung und Spielsteuerungsverfahren
DE602006018238D1 (de) Kommunikationsspielprogramm und Kommunikationsspielsystem
DK1737961T3 (da) Modificerede bouganin proteiner, cytotoxiner og fremgangsmåder og anvendelser deraf
BRPI0814085A2 (pt) Sistema, e, método
DK1943016T3 (da) Kompositnanopartikler, nanopartikler og fremgangsmåder til fremstilling heraf
BRPI0815101A2 (pt) Método, e, sistema
NL1031620A1 (nl) Lenscorrectie-element, systeem en werkwijze.
DE602005009889D1 (de) Kommunikationssystem, Kommunikationsendgerät und Kommunikationsverfahren
ATE455996T1 (de) Isolierdichtung, herstellungssystem und - verfahren
BRPI0811722A2 (pt) Método, e sistema